Insider Trading History of Laliberte Kevin


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Laliberte Kevin since year 2005. The trader's CIK number is 1709417. At the time of the last reporting, Laliberte Kevin was the Sr. VP, Product Development of Dova Pharmaceuticals Inc. . (stock ticker symbol DOVA). See this page for all insider trading activities at Dova Pharmaceuticals Inc. .


Stock purchases, sales, and option exercises reported by insider Laliberte Kevin since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2019-09-30 DOVA Dova Pharmaceuticals Inc. Sale 3,696 28.00 103,488
2019-09-25 DOVA Dova Pharmaceuticals Inc. Sale 3,100 20.00 62,000
2019-07-31 DOVA Dova Pharmaceuticals Inc. Sale 1,389 15.97 22,182
2019-07-01 DOVA Dova Pharmaceuticals Inc. Sale 1,191 14.17 16,876
2017-07-05 DOVA Dova Pharmaceuticals Inc. Buy 6,200 17.00 105,400

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Laliberte Kevin (Sr. VP, Product Development of Dova Pharmaceuticals Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.




Real-time Insider Trading

Insider Officer Cluster Trading

Top Officer Buys of the Week

Top Officer Buys of the Month